Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T21:08:55.142Z.
Calculation as of: 2026-10-06T21:08:55.142Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 08a81e5feebad721ee05cca7d6a51b618a8c436619bf2c78a545ff1cd4f886dd
PE RATIO
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jin Medical International Ltd. (ZJYL) | $15.58M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 42.19 | 43.76 | 41.41 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A | 197.01 | 197.01 | 184.62 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | N/A | 0.84 | 0.84 | 28.37 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | N/A | 6.43 | 6.43 | 6.43 |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute